On September 24, the Breast Cancer Research Foundation (BCRF) convened a critical virtual panel to address an...
Raul Delapena Setiawan
In a significant milestone for thoracic oncology, long-term data from the Phase III ADAURA trial has solidified...
Published September 19, 2026, 04:04 AM As the calendar turns toward the final week of September 2026,...
By Jessica Baladad, Breast Cancer Survivor and Patient Advocate The words "no evidence of disease" echo in...
In a decisive move to bridge the critical information gap in the oncology landscape, METAvivor, a leading...
In the rapidly evolving landscape of modern science, the traditional paradigm of the "lone genius" working in...
The biotechnology landscape is undergoing a significant structural shift as a growing cohort of emerging firms abandons...
Introduction: A New Era for Breast Cancer Care In the landscape of modern medicine, the fight against...
By Madison Decker, Charitable Advancement Manager at the National Breast Cancer Foundation (NBCF) When the conversation turns...
In a landmark development for the FemTech sector, Evvy, a pioneering health-technology firm, has successfully closed an...
